Xfenac-SP 15 Tablet

Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of inflammation by enhancing tissue permeability and reducing edema. This synergistic combination is indicated for the management of acute and chronic musculoskeletal pain, osteoarthritis, rheumatoid arthritis, postoperative pain, and soft tissue inflammatory conditions.

Xfenac-SP 15 Tablet offers rapid and sustained relief from pain and inflammation while improving functional mobility. It is generally well-tolerated; however, caution is advised in patients with gastrointestinal ulcers, hepatic or renal impairment, and hypersensitivity to NSAIDs. The medication should be used under medical supervision, adhering to prescribed dosages to minimize adverse effects such as gastrointestinal discomfort, allergic reactions, or potential drug interactions.